Skip to main content
Clinical Trials/CTRI/2024/03/063945
CTRI/2024/03/063945
Not yet recruiting
Phase 3

Comparative Effectiveness of Individualized Homoeopathic Medicine and Hydrocotyle asiatica in the treatment of Vitiligo in Paediatric age group – an Open-label, Randomised, Clinical trial - NI

ational Institute of Homoeopathy0 sites0 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: L80- Vitiligo
Sponsor
ational Institute of Homoeopathy
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Homoeopathy

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with vitiligo on the basis of clinical features.
  • Patients of all religions and socioeconomic conditions and have not taken any treatment in the last 4 weeks for vitiligo.
  • Patient willing to give informed consent and assent as required.

Exclusion Criteria

  • 1\. Patients or parents of the patient unwilling to give consent.
  • 2\. Cases with substance abuse or any psychiatric illness.
  • 3\. Congenital anomaly, critically ill and immune\-compromised patients.
  • 4\. Children suffering from uncontrolled systemic diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials